Effect of prior medical treatments on ischemic stroke severity and outcome

Functional Neurology

Volumn 26, Issue 3, 2011, Pages 133-139

  Sacco, Simona ^a   Toni, Danilo ^b   Bignamini, Angelo A ^c   Zaninelli, Augusto ^d   Gensini, Gian Franco ^d   Carolei, Antonio ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Antihypertensives; Antiplatelets; Statins; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TICLOPIDINE;

AGED; ARTICLE; BRAIN ISCHEMIA; DISEASE SEVERITY; FEMALE; FUNCTIONAL ASSESSMENT; HOSPITAL DISCHARGE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BRAIN ISCHEMIA; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ITALY; LOGISTIC MODELS; MALE; MIDDLE AGED; OBSERVATION; PLATELET AGGREGATION INHIBITORS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; STROKE; TREATMENT OUTCOME;

EID: 83455234919     PISSN: 03935264     EISSN: 19713274     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Sacco RL, Adams R, Albers G et al.; American Heart Association; American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006;37:577-617
2. Alvarez-Sabín J, Huertas R, Quintana M et al. Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator. Stroke 2007;38:1076-1078
3. Arboix A, García-Eroles L, Oliveres M, Targa C, Balcells M, Massons J. Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia? BMC Neurol 2010;10:47
4. Deplanque D, Masse I, Lefebvre C, Libersa C, Leys D, Bordet R. Prior TIA, lipid-lowering drug use, and physical activity decrease ischemic stroke severity. Neurology 2006;67:1403-1410
5. Goldstein LB, Amarenco P, Zivin J et al.; Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators. Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 2009;40:3526-3531
6. Greisenegger S, Müllner M, Tentschert S, Lang W, Lalouschek W. Effect of pretreatment with statins on the severity of acute ischemic cerebrovascular events. J Neurol Sci 2004;221:5-10
7. Elkind MS, Flint AC, Sciacca RR, Sacco RL. Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality. Neurology 2005;65:253-258
8. Jonsson N, Asplund K. Does pretreatment with statins improve clinical outcome after stroke? A pilot case-referent study. Stroke 2001;32:1112-1115
9. Martí-Fàbregas J, Gomis M, Arboix A et al. Favorable outcome of ischemic stroke in patients pretreated with statins. Stroke 2004;35:1117-1121
10. Moonis M, Kane K, Schwiderski U, Sandage BW, Fisher M. HMG-CoA reductase inhibitors improve acute ischemic stroke outcome. Stroke 2005;36:1298-1300
11. Reeves MJ, Gargano JW, Luo Z, Mullard AJ, Jacobs BS, Majid A; Paul Coverdell National Acute Stroke Registry Michigan Prototype Investigators. Effect of pretreatment with statins on ischemic stroke outcomes. Stroke 2008;39:1779-1785
12. Diener H-C, Sacco RL, Yusuf S et al.; Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a doubleblind, active and placebo-controlled study. Lancet Neurol 2008;7:875-884
13. De Keyser J, Herroelen L, De Klippel N. Early outcome in acute ischemic stroke is not influenced by the prophylactic use of low-dose aspirin. J Neurol Sci 1997;145:93-96
14. Ricci S, Lewis S, Sandercock P; IST Collaborative Group. Previous use of aspirin and baseline stroke severity: an analysis of 17,850 patients in the International Stroke Trial. Stroke 2006;37:1737-1740
15. Ovbiagele B, Buck BH, Liebeskind DS et al. Prior antiplatelet use and infarct volume in ischemic stroke. J Neurol Sci 2008;264:140-144
16. Wilterdink JL, Bendixen B, Adams HP Jr, Woolson RF, Clarke WR, Hansen MD. Effect of prior aspirin use on stroke severity in the trial of Org 10172 in acute stroke treatment (TOAST). Stroke 2001;32:2836-2840
17. Bosch J, Yusuf S, Pogue J et al.; HOPE Investigators. Heart outcomes prevention evaluation. Use of ramipril in preventing stroke: double blind randomised trial. BMJ 2002;324:699-702
18. Chitravas N, Dewey HM, Nicol MB, Harding DL, Pearce DC, Thrift AG. Is prestroke use of angiotensin-converting enzyme inhibitors associated with better outcome? Neurology 2007;68:1687-1693
19. Ovbiagele B, Kidwell CS, Starkman S et al. Angiotensin 2 type 2 receptor activity and ischemic stroke severity. Neurology 2005;65:851-854
20. Selim M, Savitz S, Linfante I, Caplan L, Schlaug G. Effect of pre-stroke use of ACE inhibitors on ischemic stroke severity. BMC Neurol 2005;5:10
21. Kumar S, Savitz S, Schlaug G, Caplan L, Selim M. Antiplatelets, ACE inhibitors, and statins combination reduces stroke severity and tissue at risk. Neurology 2006;66:1153-1158
22. Toso V, Carolei A, Gensini GF et al.; SIRIO Study Investigators: The Stroke in Italy and Related Impact on Outcome (SIRIO) study: design and baseline data. Neurol Sci 2006;27(Suppl 3):S263-267
23. Sacco S, Toni D, Bignamini AA et al. Acute stroke admission and diagnostic procedures according to hour and day of onset: the SIRIO collaborative data. Eur Neurol 2009;61:100-106
24. Brott T, Adams HP Jr, Olinger CP et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989;20:864-870
25. Chobanian AV, Bakris GL, Black HR et al.; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-1252
26. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia [http://www.who.int/diabetes/publications/en/]
27. National Institutes of Health. Adult Treatment Panel III. Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Bethesda, MD; National Institutes of Health 2002
28. Ruitenberg A, van Swieten JC, Witteman JC et al. Alcohol consumption and risk of dementia: the Rotterdam Study. Lancet 2002;359:281-286
29. World Health Organization. Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation on Obesity. Geneva; WHO 2000
30. World Health Organization. WHO Collaborating Centre for Drugs Statistics Methodology [http://www.whocc.no/atcddd/]
31. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-607
32. Wahlgren N, Ahmed N, Dávalos A et al.; SITS-MOST investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007;369:275-282
33. Hacke W, Kaste M, Fieschi C et al. Randomised doubleblind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-1251
34. Sacco S, Stracci F, Cerone D, Ricci S, Carolei A. Epidemiology of stroke in Italy. Int J Stroke 2011;6:219-227
35. Endres M, Laufs U. Discontinuation of statin treatment in stroke patients. Stroke 2006;37:2640-2643
36. FitzMaurice E, Wendell L, Snider R et al. Effect of statins on intracerebral hemorrhage outcome and recurrence. Stroke 2008;39:2151-2154
37. Leker RR, Khoury ST, Rafaeli G, Shwartz R, Eichel R, Tanne D.; NASIS Investigators. Prior use of statins improves outcome in patients with intracerebral hemorrhage: prospective data from the National Acute Stroke Israeli Surveys (NASIS). Stroke 2009;40:2581-2584
38. Naval NS, Abdelhak TA, Zeballos P, Urrunaga N, Mirski MA, Carhuapoma JR. Prior statin use reduces mortality in intracerebral hemorrhage. Neurocrit Care 2008;8: 6-12
39. Calabrò P, Yeh ET. The pleiotropic effects of statins. Curr Opin Cardiol 2005;20:541-546
40. Sacco S, Cerone D, Carolei A. Gender and stroke: acute phase treatment and prevention. Funct Neurol 2009;24: 45-52